Autonomic Medicine

Neurogenic Bladder

Neurogenic Bladder · N31.9

Neurogenic bladder is a condition in which neurological damage disrupts the normal coordination of bladder storage and emptying, caused by conditions such as spinal cord injury, multiple sclerosis, and Parkinson's disease.

2026-03-29

At a Glance

Neurogenic bladder results from disruption of neural pathways controlling bladder function. Upper motor neuron lesions (above the sacral spinal cord) cause detrusor overactivity with urgency and incontinence. Lower motor neuron lesions cause detrusor underactivity with retention. Urodynamic study is the gold-standard diagnostic test, assessing detrusor pressure, compliance, and sphincter coordination. Clean intermittent catheterization (CIC) is the cornerstone of management for urinary retention. Antimuscarinics and beta-3 agonists treat overactivity. Intravesical botulinum toxin is effective for refractory detrusor overactivity.

Definition and Overview

Neurogenic bladder refers to bladder dysfunction caused by neurological damage affecting the neural pathways that control bladder storage and emptying. Depending on the level of neurological injury, it can manifest as either an overactive (spastic) or underactive (flaccid) bladder [1].

Neuroanatomy of Bladder Control

The pontine micturition center coordinates the voiding reflex. Sacral parasympathetic nerves (S2-S4) cause detrusor contraction. Sympathetic nerves (T11-L2) promote bladder relaxation and sphincter contraction during storage. The pudendal nerve provides voluntary control of the external urethral sphincter [2].

Causes

  • Suprapontine lesions (stroke, brain tumor, dementia): detrusor overactivity with coordinated sphincter
  • Spinal cord lesions above sacral segments (spinal cord injury, MS): detrusor-sphincter dyssynergia
  • Sacral/peripheral lesions (cauda equina, diabetic neuropathy): detrusor underactivity with retention
  • Parkinson's disease: detrusor overactivity (most common urinary symptom)

Symptoms

Overactive bladder: urgency, frequency, nocturia, urge incontinence. Underactive bladder: hesitancy, weak stream, incomplete emptying, overflow incontinence [3].

Complications include recurrent UTIs, hydronephrosis, renal damage, and autonomic dysreflexia (in spinal cord injury above T6).

Diagnosis

Urodynamic study is the gold-standard test, measuring intravesical pressure, detrusor pressure, and flow rate during filling and voiding. Post-void residual (PVR) measurement quantifies incomplete emptying [4].

Video-urodynamics combine fluoroscopy with pressure measurements. Renal ultrasound assesses for hydronephrosis. Cystoscopy may be needed to rule out structural abnormalities.

Treatment

For overactive bladder: antimuscarinics (oxybutynin, solifenacin, tolterodine) or beta-3 agonists (mirabegron). Intravesical botulinum toxin injection for refractory cases [5].

For underactive bladder: clean intermittent catheterization (CIC) is the cornerstone. Alpha-blockers may improve outlet resistance. Sacral neuromodulation can improve both storage and emptying dysfunction.

General measures: timed voiding, pelvic floor exercises, adequate fluid intake, and infection prevention.

Frequently Asked Questions

FAQ content is being prepared.

References

  1. [1] Panicker JN, Fowler CJ, Kessler TM (2015). "Lower urinary tract dysfunction in the neurological patient: clinical assessment and management." Lancet Neurology, 14: 720-732. DOI PubMed
  2. [2] Ginsberg D (2013). "The epidemiology and pathophysiology of neurogenic bladder." American Journal of Managed Care, 19: S191-S196. PubMed
  3. [3] Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, Pannek J, Radziszewski P, Wyndaele JJ (2009). "EAU guidelines on neurogenic lower urinary tract dysfunction." European Urology, 56: 81-88. DOI PubMed
  4. [4] Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011). "Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity." European Urology, 60: 742-750. DOI PubMed
  5. [5] Fowler CJ, Griffiths D, de Groat WC (2008). "The neural control of micturition." Nature Reviews Neuroscience, 9: 453-466. DOI PubMed
neurogenic bladderurodynamicsCICdetrusor overactivityspinal cord injuryautonomic bladder

This content is provided for medical informational purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.